GlassScriptPhysician profile
Kevin M Audlin
NPI 1841247483
$165,759.25
in general payments reported to CMS, 2019-2025
29 companies · $12K in 2025
The $12K reported for 2025 was more than what 92% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95K · 2020: $31K · 2021: $13K · 2022: $6,022 · 2023: $905 · 2024: $8,409 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Food and Beverage: $2,692 · Travel and Lodging: $2,102 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,527.38 |
| Food and Beverage | $2,691.83 |
| Travel and Lodging | $2,102.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $106,430.79 | 2019-2024 | Olympus |
| Abbvie INC. | $35,859.73 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Intuitive Surgical, INC. | $13,882.76 | 2019-2025 | Da Vinci Surgical System |
| Conmed Corporation | $6,456.31 | 2019 | |
| Ethicon US, LLC | $564.58 | 2019-2025 | Enseal, Echelon; Endopath, Enseal X1 |
| Olympus America INC. | $455.82 | 2019-2022 | |
| Baxter Healthcare | $393.47 | 2022-2025 | Floseal, Tisseel, Adept |
| Axonics, INC. | $393.24 | 2022-2023 | Axonics |
| Sumitomo Pharma America, INC. | $201.08 | 2023 | Myfembree |
| Myovant Sciences INC. | $142.60 | 2021-2022 | |
| Hologic Sales and Service, LLC | $134.73 | 2022 | |
| Astellas Pharma US INC | $119.44 | 2023-2024 | Veozah |
| Boston Scientific Corporation | $85.42 | 2019-2024 | Upsylon |
| Caldera Medical, INC | $80.77 | 2021 | |
| Dysis Medical, INC. | $76.41 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $74.13 | 2021-2023 | Ova1 |
| Covidien LP | $68.92 | 2019 | |
| Coloplast Corp | $51.34 | 2022-2023 | Altis |
| Stryker Corporation | $50.75 | 2019 | |
| Therapeuticsmd, INC. | $39.91 | 2019 | |
| Allergan, INC. | $39.11 | 2019-2020 | |
| Pfizer INC. | $39.03 | 2022-2023 | |
| Amag Pharmaceuticals, INC. | $24.06 | 2019 | |
| Exeltis, USA INC. | $21.69 | 2023 | Slynd |
| Duchesnay USA Incorporated | $21.60 | 2019 | |
| Merck Sharp & Dohme LLC | $16.36 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.68 | 2019 | |
| Bolder Surgical LLC | $11.95 | 2019 | |
| Meditrina | $7.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Audlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.